P.

459

Intra Gastric Balloon for Obese Iraqi Patients
Yasser Fawzy Zidan; Muthanna Asaad Mohammed Wajdi; Samir I Al-Saffar; Israa E. Mohammed
National Center of Obesity, Mosul, Iraq
Introduction: The WHO recorded that nearly one third of people in Iraq
were obese, among different treatment options, the placement of an
intragastric balloon (IGB) constitutes a short-term, effective, non-surgical
intervention to lose weight.
Objectives: This study was performed to assess the safety, effectiveness and
early experience of IGB for obese Iraqi patients.
Methods: This was a prospective clinical case series study which includes
280 patients for whom IGB (MedSil) introduced, the safety assessed for all
patients while the effectiveness assessed for 100 patients who completed the
treatment period.
Results: One hundred patients (74 females and 26 males), their age 14-61
(mean 34.7 years) underwent the procedure and their balloons removed after
7-8 months. The patients lose 4-54.3 Kg (average 21.9) which was equal to
5.4 75.8 (average 31.9) percent of excess weight. Their BMI reduced 0.7 -
21 (average 8.3 ) kg/m
2
(the percent of EBMI loss 1.5 112.7). The
percentage of weight loss from the initial weight was calculated and range
between 3.6 -28.2.
The associated comorbidities improved after weight loss, and the quality of
life improved in 84% of patients depending on bariatric analysis and
reporting outcome systems (BAROS).
We recorded 2 cases of mortality from 280 (0.71%) in extreme obesity (BMI
more than 70 Kg/m
2
, these mortalities were not related to the balloon itself,
but to associated morbidities.
Conclusion: Obese and morbidly obese patients can reduce their weight
effectively by the simple procedure of intragastric balloon that decrease
morbidity and improves the quality of their life.